Epstein-Barr virus post-transplant lymphoproliferative disease (PTLD) after hematopoietic stem cell transplantation

被引：23
|
作者：
Ru, Yuhua [1 ,2 ]
Chen, Jia [1 ,2 ]
Wu, Depei [1 ,2 ]
机构：
[1] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Suzhou 215006, Peoples R China
[2] Soochow Univ, Collaborat Innovat Ctr Hematol, Inst Blood & Marrow Transplantat, Suzhou 215006, Peoples R China
来源：
EUROPEAN JOURNAL OF HAEMATOLOGY | 2018年 / 101卷 / 03期
基金：
美国国家科学基金会; 国家重点研发计划;
关键词：
EB virus; hematopoietic stem cell transplantation; lymphoproliferative disease; BONE-MARROW-TRANSPLANTATION; EBV REACTIVATION; RISK-FACTORS; VIRAL LOAD; PREEMPTIVE RITUXIMAB; PROLONGED HYPOGAMMAGLOBULINEMIA; ALLOGENEIC TRANSPLANTATION; HEART-TRANSPLANTATION; EUROPEAN CONFERENCE; PEDIATRIC-PATIENTS;
D O I：
10.1111/ejh.13131
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Epstein-Barr virus (EBV) viremia and post-transplant lymphoproliferative disease (PTLD) are severe complications after hematopoietic stem cell transplantation (HSCT). A series of risk factors have been found to predict EBV viremia and PTLD, including the T-cell depletion, reduced intensity conditioning, and alternative donor. The rituximab pre-emptive therapy could improve PTLD prognosis significantly, but the trigger of initiating rituximab pre-emptive therapy has not been well established. Additionally, EBV-specific cytotoxic T cell (CTL) is a promising approach to treat EBV-PTLD.
引用
收藏
页码：283 / 290
页数：8
相关论文
共 50 条
  • [21] Post-Transplant Lymphoproliferative Diseases in Pediatric Kidney Allograft Recipients with Epstein-Barr Virus Viremia
    Hyun, Hyesun
    Park, Eujin
    Cho, Myunghyun
    Min, Sang-Il
    Ha, Jongwon
    Kang, Hyoung Jin
    Shin, Hee Young
    Ha, Il-Soo
    Cheong, Hae Il
    Ahn, Yo Han
    Kang, Hee Gyung
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2019, 34 (30)
  • [22] Unexpected Outbreak of Epstein-Barr Virus Post-Transplantation Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation Conditioning with Thymoglobulin
    Yanez, Lucrecia
    Bermudez, Arancha
    Insunza, Andres
    Romon, Inigo
    Richard, Carlos
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (09) : 1457 - +
  • [23] The Viral Load of Epstein-Barr Virus in Blood of Children after Hematopoietic Stem Cell Transplantation*
    Jun, Wang Wen
    Qiao, Feng Shun
    Feng, He
    Jun, Du Hai
    Miao, Feng
    Fang, Wang Rui
    Yong, Mei Guo
    Mi, Liu
    Rong, Liu
    Lan, Yao Hai
    Jun, Han
    BIOMEDICAL AND ENVIRONMENTAL SCIENCES, 2022, 35 (09) : 804 - 810
  • [24] Differentiating Between Epstein-Barr Virus-positive Lymphoid Neoplasm Relapse and Post-transplant Lymphoproliferative Disorder After Sex-mismatched Hematopoietic Stem Cell Transplantation
    Kurashige, Ryumei
    Kurashige, Masako
    Okada, Yosuke
    Higuchi, Kohei
    Yuda, Sayako
    Hino, Akihisa
    Miyamura, Takako
    Ichii, Michiko
    Fukushima, Kentaro
    Honma, Keiichiro
    Takeuchi, Makoto
    Yokota, Takafumi
    Ishikawa, Jun
    Sawada, Akihisa
    Shibayama, Hirohiko
    Hosen, Naoki
    Morii, Eiichi
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2024, 48 (04) : 395 - 405
  • [25] Treatment of Epstein-Barr virus lymphoproliferative disease after hematopoietic stem-cell transplantation with hydroxyurea and cytotoxic T-cell lymphocytes
    Pakakasama, S
    Eames, GM
    Morriss, MC
    Huls, MH
    Rooney, CM
    Heslop, HE
    Krance, RA
    TRANSPLANTATION, 2004, 78 (05) : 755 - 757
  • [26] Epstein-Barr virus lymphoproliferative disease after solid organ transplantation
    Prockop, Susan E.
    Vatsayan, Anant
    CYTOTHERAPY, 2017, 19 (11) : 1270 - 1283
  • [27] Risk Factors and Predictive Scoring System For Post-Transplant Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation
    Fujimoto, Ayumi
    Hiramoto, Nobuhiro
    Yamasaki, Satoshi
    Inamoto, Yoshihiro
    Uchida, Naoyuki
    Maeda, Tetsuo
    Mori, Takehiko
    Kande, Yoshinobu
    Kondo, Tadakazu
    Shiratori, Souichi
    Miyakoshi, Shigesaburo
    Ishiyama, Ken
    Ikegame, Kazuhiro
    Matsuhashi, Yoshiko
    Tanaka, Junji
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Ogata, Masao
    Suzuki, Ritsuro
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (07) : 1441 - 1449
  • [28] B lymphocytes and Epstein-Barr virus: The lesson of post-transplant lymphoproliferative disorders
    Dolcetti, Riccardo
    AUTOIMMUNITY REVIEWS, 2007, 7 (02) : 96 - 101
  • [29] Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation
    Romero, Samuel
    Montoro, Juan
    Guinot, Marta
    Almenar, Luis
    Andreu, Rafael
    Balaguer, Aitana
    Beneyto, Isabel
    Espi, Jordi
    Gomez-Codina, Jose
    Iacoboni, Gloria
    Jarque, Isidro
    Lopez-Andujar, Rafael
    Mayordomo-Aranda, Empar
    Montalar, Joaquin
    Pastor, Amparo
    Pastor, Miguel
    Pinana, Jose L.
    Rojas-Ferrer, Nohelia
    Sanchez-Lazaro, Ignacio
    Sandoval, Jesus
    Sanz, Guillermo
    Sanz, Miguel A.
    Sole, Amparo
    Sanz, Jaime
    LEUKEMIA & LYMPHOMA, 2019, 60 (01) : 142 - 150
  • [30] Strategy of pre-emptive management of Epstein-Barr virus post-transplant lymphoproliferative disorder after stem cell transplantation: results of European transplant centers survey
    Gil, Lidia
    Styczynski, Jan
    Komarnicki, Mieczyslaw
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2012, 16 (04): : 338 - 340
12345